Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphangioma × Sclerotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lymphatic Abnormalities 1 Lymphangioma 1

Interventions

Sirolimus 2 Alpelisib 2 mirdametinib 1 Tablets 1 Surgical Procedures, Operative 1 Sclerotherapy 1 Risk Factors 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06943703 2025-04-24

Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma

National Children's Hospital, Vietnam

Lymphangioma, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon ⚡